Inventor · disambiguated record
Liselotte Bjerre Knudsen
Also filed as: KNUDSEN LISELOTTE B · KNUDSEN LISELOTTE BJERRE
9 granted patents·27 pending applications·1,031 citations·filing 1997–2014
92Inventor score
Top patents by PatentIndex Score
36 records- 0196US6458924B2Derivatives of GLP-1 analogsNOVO NORDISK AS·Filed 1999·Granted Oct 1, 2002·328 cites·20 claims
- 0296US6268343B1Derivatives of GLP-1 analogsNOVO NORDISK AS·Filed 1999·Granted Jul 31, 2001·413 cites·40 claims
- 0395US8097698B2Derivatives of GLP-1 analogsKNUDSEN LISELOTTE BJERRE·Filed 2007·Granted Jan 17, 2012·59 cites·15 claims
- 0495US7226990B2Extendin derivativesNOVO NORDISK AS·Filed 2001·Granted Jun 5, 2007·69 cites·10 claims
- 0590US8158583B2Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimiaKNUDSEN LISELOTTE BJERRE·Filed 2009·Granted Apr 17, 2012·18 cites·36 claims
- 0690US6569832B1Inhibition of beta cell degenerationNOVO NORDISK AS·Filed 2000·Granted May 27, 2003·66 cites·18 claims
- 0785US6927214B1Non-peptide GLP-1 agonistsNOVO NORDISK AS·Filed 2000·Granted Aug 9, 2005·17 cites·27 claims
- 0880US5846747AMethod for detecting glucagon-like peptide-1 antagonists and agonistsNOVO NORDISK AS·Filed 1997·Granted Dec 8, 1998·61 cites·12 claims
- 0968US2008103097A1GLP-1 derivatives IINOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1064US2006199763A1Derivatives of GLP-1 analogsKNUDSEN LISELOTTE B·Filed 2004·Application pending·0 cites
- 1164US2009149387A1Use of GLP-1 PeptidesNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 1263US2008045450A1GLP-2 DerivativesKNUDSEN LISELOTTE B·Filed 2006·Application pending·0 cites
- 1361US2008280815A1Lowering Serum LipidsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1460US2007287669A1Combined Use of Derivatives of GLP-1 Analogs and PPAR LigandsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1559US2006287221A1Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimiaNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1659US2007161568A1Use of GLP-1 peptidesNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1759US2009215688A1GLP-I Agonist And Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1857US2014206615A1Glp-1 agonist and cardiovascular complicationsNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 1956US2013338071A1GLP-1 Agonist and Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 2055US2007049531A1GLP-1 agonist and cardiovascular complationsKNUDSEN LISELOTTE B·Filed 2006·Application pending·0 cites
- 2152US2011053839A1GLP-1 Derivatives IINOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2252US2012295836A1GLP-I Agonist And Cardiovascular ComplicationsKNUDSEN LISELOTTE BJERRE·Filed 2012·Application pending·0 cites
- 2352US2004127418A1GLP-2 derivativesFiled 2003·Application pending·0 cites
- 2452US2011028391A1Use of GLP-1 PeptidesNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2552US2003232754A1Use of GLP-1 peptidesFiled 2003·Application pending·0 cites
- 2651US2011230409A1GLP-I Agonist And Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 2751US2010113363A1Use of GLP-1 PeptidesNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2851US2003220251A1Inhibition of beta cell degenerationFiled 2003·Application pending·0 cites
- 2950US2005239707A1Combined use of derivatives of GLP-1 analogs and PPAR ligandsKNUDSEN LISELOTTE B·Filed 2005·Application pending·0 cites
- 3047US2002025933A1GLP-2 derivativesFiled 2001·Application pending·0 cites
- 3146US2003220255A1GLP-1 agonist and cardiovascular complicationsFiled 2003·Application pending·0 cites
- 3245US2007082844A1Regulation of food preference using GLP-1 agonistsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 3344US2003040469A1Lowering serum lipidsFiled 2001·Application pending·0 cites
- 3444US2002187926A1Combined use of derivatives of GLP-1 analogs and PPAR ligandsFiled 2001·Application pending·0 cites
- 3535US9486504B2Regulation of food preference using GLP-1 agonistsRAUN KIRSTEN·Filed 2010·Granted Nov 8, 2016·0 cites·2 claims
- 3635US2003022816A1Combined use of derivatives of GLP-1 analogs and PPAR ligandsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liselotte Bjerre Knudsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →